Kenvue Inc. (NYSE:KVUE) Shares Bought by Cooper Investors PTY Ltd.

Cooper Investors PTY Ltd. lifted its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 39.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 858,076 shares of the company's stock after acquiring an additional 244,043 shares during the period. Kenvue accounts for approximately 3.3% of Cooper Investors PTY Ltd.'s holdings, making the stock its 9th biggest position. Cooper Investors PTY Ltd.'s holdings in Kenvue were worth $20,577,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Longbow Finance SA grew its stake in shares of Kenvue by 5.0% in the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company's stock worth $5,990,000 after purchasing an additional 13,287 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its stake in shares of Kenvue by 143.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after acquiring an additional 28,216 shares in the last quarter. CORDA Investment Management LLC. grew its holdings in shares of Kenvue by 1.4% in the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock worth $26,754,000 after acquiring an additional 17,466 shares during the last quarter. Starboard Value LP acquired a new stake in shares of Kenvue during the fourth quarter worth $467,864,000. Finally, TrueMark Investments LLC lifted its holdings in shares of Kenvue by 9.3% during the fourth quarter. TrueMark Investments LLC now owns 190,595 shares of the company's stock valued at $4,069,000 after purchasing an additional 16,161 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. UBS Group lifted their price target on Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a research note on Friday, May 9th. Redburn Atlantic initiated coverage on shares of Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 target price on the stock. Evercore ISI assumed coverage on shares of Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 price target on the stock. Citigroup reaffirmed a "neutral" rating on shares of Kenvue in a research note on Friday, June 13th. Finally, Barclays lifted their price objective on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and a consensus price target of $25.33.

Kenvue Stock Down 1.1%

Shares of NYSE:KVUE traded down $0.23 during trading on Friday, reaching $20.89. 24,148,905 shares of the company traded hands, compared to its average volume of 16,266,399. The firm has a fifty day simple moving average of $22.85 and a 200 day simple moving average of $22.37. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $25.17. The firm has a market cap of $40.07 billion, a P/E ratio of 37.97, a price-to-earnings-growth ratio of 3.29 and a beta of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same period last year, the company earned $0.28 earnings per share. Kenvue's quarterly revenue was down 3.9% compared to the same quarter last year. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were paid a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.93%. Kenvue's payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.